miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
α-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs
Yi, R., O'Carroll, D., Pasolli, H. A., Zhang, Z., Dietrich, F. S., Tarakhovsky, A., & Fuchs, E. (2006) · Nature Genetics · doi:10.1038/ng1744 · Cited by 555
Pancreatic organogenesis — developmental mechanisms and implications for therapy
Edlund, H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg841 · Cited by 523
Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release.
Bonner-Weir, S., Trent, D. F., & Weir, G. C. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110910 · Cited by 467 · cited 1×
“The hyperglycemic phenotype of 375KO animals is unlikely due to the moderate (25%) decrease in -cell mass because this reduction is usually insufficient to cause insulin deficiency and diabetes (30), and amounts of insulin secretion by isolated pancreatic islets from mutant and wild-type mice in response to various co…”
BackgroundKloosterman, W. P., Lagendijk, A. K., Ketting, R. F., Moulton, J. D., & Plasterk, R. H. A. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050203 · Cited by 464
TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer
Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H. P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T., et al. (2001) · Nature Genetics · doi:10.1038/86934 · Cited by 441 · cited 1×
“Published studies have shown that these genes play a role in the p53-dependent pathway (17–19), MAP kinase signaling (20), inducing apoptosis (21–23), and inhibiting normal developmental growth processes (24, 25) or the proliferation of tumors in mice (26, 27).”
BackgroundAltered control of cellular proliferation in the absence of mammalian brahma (SNF2α)
Reyes, J. C., Barra, J., Muchardt, C., Camus, A., Babinet, C., & Yaniv, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6979 · Cited by 433
Kulkarni, R. N., Holzenberger, M., Shih, D. Q., Ozcan, U., Stoffel, M., Magnuson, M. A., & Kahn, C. R. (2002) · Nature Genetics · doi:10.1038/ng872 · Cited by 363
Self-citationMicroRNA Expression Is Required for Pancreatic Islet Cell Genesis in the Mouse
Lynn, F. C., Skewes-Cox, P., Kosaka, Y., McManus, M. T., Harfe, B. D., & German, M. S. (2007) · Diabetes · doi:10.2337/db07-0175 · Cited by 351 · cited 2×
“For instance, mutant mice in which miRNAs are collectively silenced during endocrine pancreas development exhibit defects in all pancreatic lineages, including a dramatic reduction of insulin-producing cells (8).”
BackgroundIncreased islet apoptosis in Pdx1+/– mice
Johnson, J. D., Ahmed, N. T., Luciani, D. S., Han, Z., Tran, H., Fujita, J., Misler, S., Edlund, H., & Polonsky, K. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16537 · Cited by 342
Increased islet apoptosis in Pdx1+/– mice
Johnson, J. D., Ahmed, N. T., Luciani, D. S., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316537 · Cited by 308
Galbiati, F., Volonte', D., Liu, J., Capozza, F., Frank, P. G., Zhu, L., Pestell, R. G., & Lisanti, M. P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2229 · Cited by 259
Cohen, A. W., Park, D. S., Woodman, S. E., Williams, T. M., Chandra, M., Shirani, J., Pereira de Souza, A., Kitsis, R. N., Russell, R. G., Weiss, L. M., et al. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00380.2002 · Cited by 233 · cited 1×
“Published studies have shown that these genes play a role in the p53-dependent pathway (17–19), MAP kinase signaling (20), inducing apoptosis (21–23), and inhibiting normal developmental growth processes (24, 25) or the proliferation of tumors in mice (26, 27).”
BackgroundThe RNA-binding protein HuD regulates neuronal cell identity and maturation
Akamatsu, W., Fujihara, H., Mitsuhashi, T., Yano, M., Shibata, S., Hayakawa, Y., Okano, H. J., Sakakibara, S.-I., Takano, H., Takano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407523102 · Cited by 222 · cited 1×
“Published studies have shown that these genes play a role in the p53-dependent pathway (17–19), MAP kinase signaling (20), inducing apoptosis (21–23), and inhibiting normal developmental growth processes (24, 25) or the proliferation of tumors in mice (26, 27).”
BackgroundCheung, E. C., Joza, N., Steenaart, N. A., McClellan, K. A., Neuspiel, M., McNamara, S., MacLaurin, J. G., Rippstein, P., Park, D. S., Shore, G. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601276 · Cited by 191
Increased Islet Volume but Unchanged Islet Number in ob/ob Mice
Bock, T., Pakkenberg, B., & Buschard, K. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1716 · Cited by 188 · cited 1×
“To further address the role of miR-375 in the maintenance of -cell mass, we measured miR-375 expression in pancreatic islets isolated from ob/ob mice, a model for increased islet mass that is induced by severe insulin resistance (14).”
BackgroundGlycemic Control in Mice with Targeted Disruption of the Glucagon Receptor Gene
Parker, J. C., Andrews, K. M., Allen, M. R., Stock, J. L., & McNeish, J. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6265 · Cited by 162 · cited 1×
“Alternatively, the increase in -cell number could be the result of a compensatory response to altered -cell mass and function or to the chronic hyperglucagonemia, which in some models is associated with -cell hyperplasia (31, 32).”
BackgroundThe Haploinsufficient Tumor Suppressor p18 Upregulates p53 via Interactions with ATM/ATR
Park, B.-J., Kang, J. W., Lee, S., Choi, S., Shin, Y. K., Ahn, Y. H., Choi, Y. H., Choi, D., Lee, K. S., & Kim, S. (2005) · Cell · doi:10.1016/j.cell.2004.11.054 · Cited by 154
Chen, M., Gavrilova, O., Zhao, W.-Q., Nguyen, A., Lorenzo, J., Shen, L., Nackers, L., Pack, S., Jou, W., & Weinstein, L. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24196 · Cited by 141
The Ras-related protein AGS1/RASD1 suppresses cell growth
Vaidyanathan, G., Cismowski, M. J., Wang, G., Vincent, T. S., Brown, K. D., & Lanier, S. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207774 · Cited by 121 · cited 1×
“Published studies have shown that these genes play a role in the p53-dependent pathway (17–19), MAP kinase signaling (20), inducing apoptosis (21–23), and inhibiting normal developmental growth processes (24, 25) or the proliferation of tumors in mice (26, 27).”
BackgroundShih, D. Q., Heimesaat, M., Kuwajima, S., Stein, R., Wright, C. V. E., & Stoffel, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062605899 · Cited by 96
Self-citationThe p53 tumor suppressor targets a novel regulator of G protein signaling
Buckbinder, L., Velasco-Miguel, S., Chen, Y., Xu, N., Talbott, R. L., Gelbert, L., Gao, J., Seizinger, B. R., Gutkind, J. S., & Kley, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7868 · Cited by 92
Joe, M. K., Lee, H., Suh, Y. H., Han, K. L., Lim, J. H., Song, J., Seong, J. K., & Jung, M. H. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.005 · Cited by 67
Kamal, A., & Datta, K. (2006) · APOPTOSIS · doi:10.1007/s10495-006-5396-4 · Cited by 45
Id3 Induces Growth Arrest and Caspase-2-Dependent Apoptosis in B Lymphocyte Progenitors
Kee, B. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4518 · Cited by 30
Borelli, M. I., Rubio‐Terres, C., García, M. E., Flores, L. E., & Gagliardino, J. J. (2003) · BMC Endocrine Disorders · doi:10.1186/1472-6823-3-2 · Cited by 25
In vivo and in vitro Studies of Gluconeogenesis in Meal-fed and Nibbling Rats
Leveille, G. A., & Chakrabarty, K. (1968) · Journal of Nutrition · doi:10.1093/jn/96.3.397 · Cited by 20 · cited 1×
“In vivo gluconeogenesis studies were performed as previously described (35).”
Method
Cited by
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
MicroRNAs in Stress Signaling and Human Disease
Mendell, J. T., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.02.005 · Cited by 1,673
“The endocrine pancreas develops normally in miR-375 / mice yet these animals fail to appropriately expand pancreatic b cell mass in the setting of obesity-induced insulin resistance, resulting in severe diabetes (Poy et al., 2009).”
BackgroundHammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,284
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.